PARP1 and cancer: Their nano-encapsulation, using liposomes, PLGA (poly-lactic-co-glycolic acid) nanoparticles, solid lipid nanoparticles (SLNs), or gold nanoparticles (AuNPs), has shown promise in targeting PARP-dependent signalling and DNA repair pathways in preclinical cancer models [55,152].